vs

Side-by-side financial comparison of ACME UNITED CORP (ACU) and RxSight, Inc. (RXST). Click either name above to swap in a different company.

ACME UNITED CORP is the larger business by last-quarter revenue ($52.3M vs $32.6M, roughly 1.6× RxSight, Inc.). ACME UNITED CORP runs the higher net margin — 1.9% vs -28.1%, a 30.0% gap on every dollar of revenue. On growth, ACME UNITED CORP posted the faster year-over-year revenue change (13.8% vs -18.9%). Over the past eight quarters, RxSight, Inc.'s revenue compounded faster (5.1% CAGR vs -2.9%).

Acme United Corporation is a supplier of cutting, measuring and safety products for the school, home, office, hardware and industrial markets. The company was organized as a partnership in 1867 and incorporated in 1873 under the laws of the State of Connecticut. It is publicly traded on the NYSE American with symbol ACU.

RxSight, Inc. is a medical technology company focused on developing and commercializing innovative intraocular lens solutions for patients undergoing cataract and refractive lens exchange procedures. Its flagship Light Adjustable Lens allows post-surgery power adjustment via a dedicated light delivery device, serving global ophthalmology care markets to improve post-operative visual outcomes for patients.

ACU vs RXST — Head-to-Head

Bigger by revenue
ACU
ACU
1.6× larger
ACU
$52.3M
$32.6M
RXST
Growing faster (revenue YoY)
ACU
ACU
+32.7% gap
ACU
13.8%
-18.9%
RXST
Higher net margin
ACU
ACU
30.0% more per $
ACU
1.9%
-28.1%
RXST
Faster 2-yr revenue CAGR
RXST
RXST
Annualised
RXST
5.1%
-2.9%
ACU

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
ACU
ACU
RXST
RXST
Revenue
$52.3M
$32.6M
Net Profit
$985.0K
$-9.2M
Gross Margin
39.7%
77.5%
Operating Margin
3.3%
-34.8%
Net Margin
1.9%
-28.1%
Revenue YoY
13.8%
-18.9%
Net Profit YoY
-40.4%
-54.1%
EPS (diluted)
$0.24
$-0.22

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ACU
ACU
RXST
RXST
Q1 26
$52.3M
Q4 25
$47.5M
$32.6M
Q3 25
$49.1M
$30.3M
Q2 25
$54.0M
$33.6M
Q1 25
$46.0M
$37.9M
Q4 24
$45.9M
$40.2M
Q3 24
$48.2M
$35.3M
Q2 24
$55.4M
$34.9M
Net Profit
ACU
ACU
RXST
RXST
Q1 26
$985.0K
Q4 25
$1.9M
$-9.2M
Q3 25
$1.9M
$-9.8M
Q2 25
$4.8M
$-11.8M
Q1 25
$1.7M
$-8.2M
Q4 24
$1.7M
$-5.9M
Q3 24
$2.2M
$-6.3M
Q2 24
$4.5M
$-6.1M
Gross Margin
ACU
ACU
RXST
RXST
Q1 26
39.7%
Q4 25
38.2%
77.5%
Q3 25
39.1%
79.9%
Q2 25
41.0%
74.9%
Q1 25
39.0%
74.8%
Q4 24
38.7%
71.6%
Q3 24
38.5%
71.4%
Q2 24
40.8%
69.5%
Operating Margin
ACU
ACU
RXST
RXST
Q1 26
3.3%
Q4 25
6.1%
-34.8%
Q3 25
6.1%
-40.1%
Q2 25
11.8%
-41.6%
Q1 25
5.3%
-28.2%
Q4 24
5.0%
-21.5%
Q3 24
6.1%
-26.1%
Q2 24
11.5%
-23.9%
Net Margin
ACU
ACU
RXST
RXST
Q1 26
1.9%
Q4 25
3.9%
-28.1%
Q3 25
3.9%
-32.4%
Q2 25
8.8%
-35.0%
Q1 25
3.6%
-21.6%
Q4 24
3.7%
-14.8%
Q3 24
4.6%
-17.9%
Q2 24
8.0%
-17.4%
EPS (diluted)
ACU
ACU
RXST
RXST
Q1 26
$0.24
Q4 25
$0.46
$-0.22
Q3 25
$0.46
$-0.24
Q2 25
$1.16
$-0.29
Q1 25
$0.41
$-0.20
Q4 24
$0.43
$-0.14
Q3 24
$0.54
$-0.16
Q2 24
$1.09
$-0.16

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ACU
ACU
RXST
RXST
Cash + ST InvestmentsLiquidity on hand
$4.2M
$228.1M
Total DebtLower is stronger
$33.0M
Stockholders' EquityBook value
$116.7M
$275.7M
Total Assets
$195.2M
$311.8M
Debt / EquityLower = less leverage
0.28×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ACU
ACU
RXST
RXST
Q1 26
$4.2M
Q4 25
$3.6M
$228.1M
Q3 25
$5.1M
$227.5M
Q2 25
$3.6M
$227.5M
Q1 25
$3.4M
$229.3M
Q4 24
$6.4M
$237.2M
Q3 24
$5.7M
$237.1M
Q2 24
$3.8M
$233.3M
Total Debt
ACU
ACU
RXST
RXST
Q1 26
$33.0M
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Stockholders' Equity
ACU
ACU
RXST
RXST
Q1 26
$116.7M
Q4 25
$117.6M
$275.7M
Q3 25
$115.8M
$276.0M
Q2 25
$113.7M
$278.0M
Q1 25
$108.3M
$279.3M
Q4 24
$107.0M
$281.2M
Q3 24
$106.3M
$277.3M
Q2 24
$104.0M
$275.2M
Total Assets
ACU
ACU
RXST
RXST
Q1 26
$195.2M
Q4 25
$171.0M
$311.8M
Q3 25
$173.0M
$308.5M
Q2 25
$170.9M
$309.0M
Q1 25
$163.0M
$313.0M
Q4 24
$162.2M
$318.6M
Q3 24
$165.5M
$310.5M
Q2 24
$173.5M
$305.5M
Debt / Equity
ACU
ACU
RXST
RXST
Q1 26
0.28×
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ACU
ACU
RXST
RXST
Operating Cash FlowLast quarter
$-1.1M
Free Cash FlowOCF − Capex
$-2.3M
FCF MarginFCF / Revenue
-6.9%
Capex IntensityCapex / Revenue
3.5%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-19.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ACU
ACU
RXST
RXST
Q1 26
Q4 25
$8.2M
$-1.1M
Q3 25
$7.1M
$-1.2M
Q2 25
$6.3M
$-4.4M
Q1 25
$-3.3M
$-8.8M
Q4 24
$6.4M
$-4.3M
Q3 24
$8.9M
$650.0K
Q2 24
$6.9M
$-4.0M
Free Cash Flow
ACU
ACU
RXST
RXST
Q1 26
Q4 25
$7.3M
$-2.3M
Q3 25
$301.0K
$-1.8M
Q2 25
$4.7M
$-5.9M
Q1 25
$-4.7M
$-9.4M
Q4 24
$4.7M
$-5.1M
Q3 24
$7.5M
$-453.0K
Q2 24
$4.4M
$-5.5M
FCF Margin
ACU
ACU
RXST
RXST
Q1 26
Q4 25
15.3%
-6.9%
Q3 25
0.6%
-5.8%
Q2 25
8.7%
-17.6%
Q1 25
-10.2%
-24.8%
Q4 24
10.2%
-12.7%
Q3 24
15.6%
-1.3%
Q2 24
8.0%
-15.9%
Capex Intensity
ACU
ACU
RXST
RXST
Q1 26
Q4 25
1.9%
3.5%
Q3 25
13.8%
1.9%
Q2 25
3.0%
4.6%
Q1 25
2.9%
1.5%
Q4 24
3.7%
2.1%
Q3 24
2.8%
3.1%
Q2 24
4.5%
4.4%
Cash Conversion
ACU
ACU
RXST
RXST
Q1 26
Q4 25
4.34×
Q3 25
3.72×
Q2 25
1.33×
Q1 25
-2.02×
Q4 24
3.73×
Q3 24
3.99×
Q2 24
1.55×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ACU
ACU

Segment breakdown not available.

RXST
RXST

Rxlal$28.2M86%
LDD$3.0M9%
Service Warranty Service Contracts And Accessories$1.5M4%

Related Comparisons